Back to results
US 12,564,567 B2Granted
Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virus
AssigneeVireo Systems, Inc.
InventorsMark C. Faulkner, Donald W. Miller
Life of this patent
Estimating the term…
Abstract
Antiviral therapeutic compounds and compositions that may be used in methods of preventing and/or treating infection(s) caused by coronaviruses or influenza viruses.
Claims22
A method of reducing inflammatory response to viral proteins in a patient in need thereof, comprising:
- administering to the patient an effective amount of a composition comprising at least one antiviral therapeutic compound, wherein the antiviral therapeutic compound is selected from the group consisting of creatine cyclohexyl ester, creatine isopentyl ester, betaine cyclopentyl ester, and combinations thereof.
A method of reducing inflammatory response to viral proteins in a patient in need thereof, comprising:
- administering to the patient an effective amount of at least one antiviral therapeutic compound, wherein the antiviral therapeutic compound is selected from the group consisting of creatine cyclohexyl ester, creatine isopentyl ester, betaine cyclopentyl ester, and combinations thereof.
A method of reducing inflammatory response to viral proteins in a patient in need thereof, comprising:
- administering to the patient an effective amount of a composition comprising at least one antiviral therapeutic compound and at least one anti-inflammatory agent, wherein the antiviral therapeutic compound is selected from the group consisting of creatine cyclohexyl ester, creatine isopentyl ester, betaine cyclopentyl ester, and a combination thereof and wherein the anti-inflammatory agent comprises ethyl (α-guanido-methyl) ethanoate, wherein the antiviral therapeutic compound is present in the composition in an amount of about 50 percent or greater by weight of the composition.
Dependencies are inferred from the claim text.